Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Martinot

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
Hepatology (Baltimore, Md.)|April 16, 1998
Re-treatment with interferon alfa of patients with chronic hepatitis CW C Chow, N Boyer, M Pouteau, et al.
Journal of Viral Hepatitis|October 15, 2013
IFNL3 (IL28B) polymorphism does not predict long-term response to interferon therapy in HBeAg-positive chronic hepatitis B patientsQ Zhang, M Lapalus, T Asselah, et al.
Gut|August 13, 2009
Insulin resistance and geographical origin: major predictors of liver fibrosis and response to peginterferon and ribavirin in HCV-4R Moucari, M-P Ripault, M Martinot-Peignoux, et al.
Infectious Diseases Now|July 9, 2021
Predictors of mortality, ICU hospitalization, and extrapulmonary complications in COVID-19 patientsM Martinot, M Eyriey, S Gravier, et al.
Clinical Biochemistry|June 16, 2001
Cytokines as predictors for sustained response and as markers for immunomodulation in patients with chronic hepatitis CM G Neuman, J P Benhamou, I M Malkiewicz, et al.
Infectious Diseases Now|December 13, 2021
Changing profile of encephalitis: Results of a 4-year study in FranceA Mailles, X Argemi, C Biron, et al.
Journal of Viral Hepatitis|December 22, 1999
Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to interferon therapy. The GEMHEPM Martinot-Peignoux, F Roudot-Thoraval, I Mendel, et al.
Infectious Diseases Now|February 12, 2022
3D-printed simulator for nasopharyngeal swab collection for COVID-19A Koch, M Vermel, Y Hansmann, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 31, 2015
A Model-Based Illustrative Exploratory Approach to Optimize the Dosing of Peg-IFN/RBV in Cirrhotic Hepatitis C Patients Treated With Triple TherapyC Laouénan, J Guedj, G Peytavin, et al.
Medicine|May 14, 2016
Infections Revealing Complement Deficiency in Adults: A French Nationwide Study Enrolling 41 PatientsA Audemard-Verger, E Descloux, D Ponard, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Hepatology (Baltimore, Md.)|April 16, 1998
Re-treatment with interferon alfa of patients with chronic hepatitis CW C Chow, N Boyer, M Pouteau, et al.
Journal of Viral Hepatitis|October 15, 2013
IFNL3 (IL28B) polymorphism does not predict long-term response to interferon therapy in HBeAg-positive chronic hepatitis B patientsQ Zhang, M Lapalus, T Asselah, et al.
Gut|August 13, 2009
Insulin resistance and geographical origin: major predictors of liver fibrosis and response to peginterferon and ribavirin in HCV-4R Moucari, M-P Ripault, M Martinot-Peignoux, et al.
Infectious Diseases Now|July 9, 2021
Predictors of mortality, ICU hospitalization, and extrapulmonary complications in COVID-19 patientsM Martinot, M Eyriey, S Gravier, et al.
Clinical Biochemistry|June 16, 2001
Cytokines as predictors for sustained response and as markers for immunomodulation in patients with chronic hepatitis CM G Neuman, J P Benhamou, I M Malkiewicz, et al.
Infectious Diseases Now|December 13, 2021
Changing profile of encephalitis: Results of a 4-year study in FranceA Mailles, X Argemi, C Biron, et al.
Journal of Viral Hepatitis|December 22, 1999
Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to interferon therapy. The GEMHEPM Martinot-Peignoux, F Roudot-Thoraval, I Mendel, et al.
Infectious Diseases Now|February 12, 2022
3D-printed simulator for nasopharyngeal swab collection for COVID-19A Koch, M Vermel, Y Hansmann, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 31, 2015
A Model-Based Illustrative Exploratory Approach to Optimize the Dosing of Peg-IFN/RBV in Cirrhotic Hepatitis C Patients Treated With Triple TherapyC Laouénan, J Guedj, G Peytavin, et al.
Medicine|May 14, 2016
Infections Revealing Complement Deficiency in Adults: A French Nationwide Study Enrolling 41 PatientsA Audemard-Verger, E Descloux, D Ponard, et al.
Pageof 12